Skip to content
Politically.com Search all
Menu

2026 · 1st Quarter (Jan 1 - Mar 31)

ULTRAGENYX PHARMACEUTICAL INC.

Filed by ULTRAGENYX PHARMACEUTICAL INC..

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-09-15 06:26:11 UTC.

Source-reported fields

Filing overview

Type
1st Quarter - Report
Posted
Apr 17, 2026
Income
Not reported
Expenses
$440,000.00
Filing UUID
a9a9c3da-02f4-4c7e-8bca-c0bd10ed47f3
Termination date
Not reported

Expense method: A

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

Issues related to drug development, access and reimbursement for rare and ultra rare diseases.

BUD · Budget/Appropriations

Issues related to drug development, access and reimbursement for rare and ultra rare diseases.

MMM · Medicare/Medicaid

Issues related to drug development, access and reimbursement for rare and ultra rare diseases.

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.